Compare Incyte Corporation (INCY) vs Marsh & McLennan Companies, Inc. (MRSH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Incyte Corporation vs Marsh & McLennan Companies, Inc. — how do they compare? Incyte Corporation trades at $115.7 (market cap $23.11B), while Marsh & McLennan Companies, Inc. trades at $180.6 (market cap $87.77B). The key difference: Marsh & McLennan Companies, Inc. is far larger — about 3.8× Incyte Corporation's market cap, and Marsh & McLennan Companies, Inc. pays a 2.17% dividend while Incyte Corporation pays none. Which is the better fit depends on your goals.
| INCY | MRSH | |
|---|---|---|
Market Cap | $23.11B | $87.77B |
Sector | Health | Financials |
52-Week High | $118.52 | $211.21 |
52-Week Low | $67.38 | $157.32 |
Enterprise Value | $19.13B | $108.61B |
Dividend Yield | — | 2.17% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Incyte Corporation
Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis. Incyte's pipeline includes a broad array of oncology and dermatology programs.
Read more on INCY →About Marsh & McLennan Companies, Inc.
Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).
Read more on MRSH →
